Picture of Bioventus logo

BVS Bioventus Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Bioventus, fiscal year end - December 31st, millions except per share.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
Status:
fx
Preliminary
FinalFinalFinalFinal
Net Income/Starting Line-12.26.314.79.59
Depreciation
Deferred Taxes
Non-Cash Items25.41813.61.56
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital2.85-13.615.3-13.3
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities45.240.771.823
Capital Expenditures-2.56-2.34-4.09-7.37
Purchase of Fixed Assets
Other Investing Cash Flow Items-3.54-5.57-16.4-276
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-6.1-7.91-20.5-284
Financing Cash Flow Items-7.85-9.5-19.6-2.24
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-13.3-11-29.6273
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash25.721.722.312.4

Or unlock with your email

Or unlock with your email